Optimal control in a model of dendritic cell transfection cancer immunotherapy

From MaRDI portal
Publication:263587

DOI10.1007/s11538-005-9014-3zbMath1334.92191OpenAlexW1977466091WikidataQ51939241 ScholiaQ51939241MaRDI QIDQ263587

Filippo Castiglione, Benedetto Piccoli

Publication date: 5 April 2016

Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1007/s11538-005-9014-3




Related Items (36)

A mathematical prognosis model for pancreatic cancer patients receiving immunotherapyDendritic immunotherapy improvement for an optimal control murine modelOptimal control with isoperimetric constraint for chemotherapy of tumorsMathematical modelling of cancer stem cell-targeted immunotherapyPulse HIV vaccination: feasibility for virus eradication and optimal vaccination scheduleAn extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocolA mathematical model of combined \textit{bacillus Calmette-Guerin} (BCG) and interleukin (IL)-2 immunotherapy of superficial bladder cancerA nonlinear mathematical model of cell-mediated immune response for tumor phenotypic heterogeneityA tumor-Immune interaction model with the effect of impulse therapyOptimizing the timing and composition of therapeutic phage cocktails: a control-theoretic approachTumor Control, Elimination, and Escape through a Compartmental Model of Dendritic Cell Therapy for MelanomaMetaheuristics and Pontryagin's minimum principle for optimal therapeutic protocols in cancer immunotherapy: a case study and methods comparisonOn the optimal control problem for a model of the synergy of chemo‐ and immunotherapyA model of tumor‐immune system interactions with healthy cells and immunotherapiesBang-bang optimal controls for a mathematical model of chemo- and immunotherapy in cancerOPTIMAL TREATMENT STRATEGIES USING DENDRITIC CELL VACCINATION FOR A TUMOR MODEL WITH PARAMETER IDENTIFIABILITYA PROGNOSTIC IMMUNOTHERAPY MODEL FOR 4T1 BREAST CANCER WITH COMBINED CYCLOPHOSPHAMIDE AND TLR AGONISTA MATHEMATICAL MODEL OF PANCREATIC CANCER WITH TWO KINDS OF TREATMENTSOptimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancerA new conceptual framework for the therapy by optimized multidimensional pulses of therapeutic activity. The case of multiple myeloma modelOPTIMAL CONTROL OF MIXED IMMUNOTHERAPY AND CHEMOTHERAPY OF TUMORSCancer immunotherapy, mathematical modeling and optimal controlDetermination of the optimal therapeutic protocols in cancer immunotherapyOptimal response to chemotherapy for a mathematical model of tumor-immune dynamicsModelling pulsed immunotherapy of tumour-immune interactionControlling IL-7 injections in HIV-infected patientsMathematical models for immunology: current state of the art and future research directionsA mathematical model of the enhancement of tumor vaccine efficacy by immunotherapySpatial avascular growth of tumor in a homogeneous environmentOptimization of combination therapy for chronic myeloid leukemia with dosing constraintsOptimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesisEquilibria and control of metabolic networks with enhancers and inhibitorsMATHEMATICAL MODELING OF PANCREATIC CANCER TREATMENT WITH CANCER STEM CELLSOn optimal delivery of combination therapy for tumorsPERIODICALLY PULSED IMMUNOTHERAPY IN A MATHEMATICAL MODEL OF TUMOR-IMMUNE INTERACTIONAnalysis of stochastic dynamics of tumor with drug interventions



Cites Work


This page was built for publication: Optimal control in a model of dendritic cell transfection cancer immunotherapy